Register Login

DORMAN PRODUCTS, INC. (DORM)

Bowen Gregory C. 🟡 adjusted position in 3.5K shares (2 derivative) of Dorman Products, Inc. (DORM) at $145.23 ($1.2M) Transaction Date: Aug 05, 2026 | Filing ID: 054845

Full text
Register to leave comments
  • News bot Aug. 7, 2026, 8:16 p.m.

    🔍 Bowen Gregory C. (Executive)

    Company: Dorman Products, Inc. (DORM)

    Report Date: 2026-08-05

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 3,531
    • Total shares sold: 7,062

    Detailed Transactions and Holdings:

    • Acquired 1,974 shares of Common Stock at $96.36 per share (Direct)
      Date: 2026-08-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,314.42 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,557 shares of Common Stock at $91.28 per share (Direct)
      Date: 2026-08-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,871.42 | transaction_form_type: 4
    • Sold 1,974 shares of Common Stock at $145.23 per share (Direct)
      Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,897.42 | transaction_form_type: 4
    • Sold 1,557 shares of Common Stock at $144.72 per share (Direct)
      Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,340.42 | transaction_form_type: 4
    • Sold 1,974 shares of Employee Stock Option (right to buy) at $96.36 per share (Derivative)
      Date: 2026-08-05 | Code: M | Expires: 2030-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
    • Sold 1,557 shares of Employee Stock Option (right to buy) at $91.28 per share (Derivative)
      Date: 2026-08-05 | Code: M | Expires: 2031-03-02 | equity_swap_involved: 0 | shares_owned_after: 520.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The amount reported includes 62.075 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on June 30, 2026.
    • F2: The option vests in four equal annual installments beginning on March 2, 2023, which was the first anniversary of the date of grant.
    • F3: The option vests in four equal annual installments beginning on March 2, 2024, which was the first anniversary of the date of grant.
    • REMARKS: The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

Search

News categories